In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
“If our patients are diverse, why are clinical trials so white?” Vanessa Sheppard, PhD, invoked this quote from author and...
AACR on Campus – Defeating Cancer through Global Education and Training is a global outreach program that will bring...
While cancer and COVID-19 are, biologically, very different diseases, they have shaken the world in surprisingly similar ways. Nearly...
Among the studies published during the month of October in the nine AACR journals, the editors have chosen to highlight results from two clinical trials of DNA...
Guest post by Patrick Tan, MD, PhD From November 1-3, 2021, Singapore will hold its 13th Frontiers in Cancer...
Due to advances in screening and treatment, the survival rate for patients with breast cancer has increased in recent decades. However, this progress...
Monday afternoon, First Lady Jill Biden visited the Medical University of South Carolina (MUSC) Hollings Cancer Center as part...
Once considered undruggable, mutant KRAS has emerged in recent years as a viable target for anticancer therapeutics. As a...
Liver cancer is the second most common cause of cancer-related deaths worldwide. In 2021, it is estimated that more...
One year, to the day, after winning the Nobel Prize in Chemistry for her groundbreaking work on the genetic...